SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009191
Filing Date
2019-05-09
Accepted
2019-05-09 08:52:07
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20190331_10q.htm 10-Q 1179270
2 EXHIBIT 5.1 ex_143681.htm EX-5.1 12950
3 EXHIBIT 31.1 ex_143467.htm EX-31.1 10685
4 EXHIBIT 31.2 ex_143468.htm EX-31.2 10653
5 EXHIBIT 32.1 ex_143469.htm EX-32.1 7880
12 cooley.jpg GRAPHIC 4331
  Complete submission text file 0001437749-19-009191.txt   4896737

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acrx-20190331.xml EX-101.INS 984301
7 XBRL TAXONOMY EXTENSION SCHEMA acrx-20190331.xsd EX-101.SCH 55802
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20190331_cal.xml EX-101.CAL 41435
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20190331_def.xml EX-101.DEF 297747
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20190331_lab.xml EX-101.LAB 264878
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20190331_pre.xml EX-101.PRE 325486
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 19808970
SIC: 2834 Pharmaceutical Preparations